Fraxiparine Forte

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Nadroparin calcium 19000 anti-Xa IU/mL

Disponible desde:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

Designación común internacional (DCI):

Nadroparin calcium 19000 anti-Xa IU/mL

Dosis:

19000 anti-Xa IU/mL

formulario farmacéutico:

Solution for injection

Composición:

Active: Nadroparin calcium 19000 anti-Xa IU/mL Excipient: Calcium hydroxide Hydrochloric acid Water for injection

Unidades en paquete:

Syringe, glass, 1mL x2, 2 dose units

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Glaxo Wellcome Production

indicaciones terapéuticas:

Treatment of deep vein thrombosis

Resumen del producto:

Package - Contents - Shelf Life: Syringe, glass, 1mL x2 - 2 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.8mL x2 - 2 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.6mL x2 - 2 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 1mL x6 - 6 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.8mL x6 - 6 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.6mL x6 - 6 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 1mL x10 - 10 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.8mL x10 - 10 dose units - 24 months from date of manufacture stored at or below 30°C - Syringe, glass, 0.6mL x10 - 10 dose units - 24 months from date of manufacture stored at or below 30°C

Fecha de autorización:

1997-10-24